
Leqembi shows lower progression rate in Alzheimer disease over 3 years, shows new data.
Read the full, exclusive transcript from the inaugural "Brain Trust: Conversations in Clinical Psychopharmacology" video with Joseph F. Goldberg, MD, and Marlene Freeman, MD.
BRAIN TRUST: CONVERSATIONS IN PSYCHOPHARMACOLOGY



